Youngevity International (YGYI) Announces Results of Youngevity® Research Studies Performed by the Richardson Center for Functional Foods and Nutraceuticals - University of Manitoba
San Diego, CA - May 28, 2014 – Youngevity International, Inc. (OTCQX: YGYI) (www.YGYI.com), a global direct marketer of lifestyle and nutritional products and gourmet coffee, announced today the exciting results of research studies performed at the prestigious Richardson Center for Functional Foods and Nutraceuticals (RCFFN) at the University of Manitoba (www.rcffn.ca).
The RCFFN is one of the most advanced bioprocessing and product development facilities in the world that focuses on the research, discovery, and development of innovative functional foods and nutraceuticals. The research team at the RCFFN evaluated the safety and health benefits of the following Youngevity® signature products; Beyond Tangy Tangerine 2.0 and the Healthy Start Pak 2.0, which consists of the Beyond Tangy Tangerine 2.0, Beyond OsteoFx 2.0, and Ultimate Essential Fatty Acids.
The study was overseen by Dr. Peter Jones, Director of the RCFFN and one of the world’s foremost researchers in dietary and nutraceutical determinants in the control of fat, energy metabolism, and various other critical health issues. Additionally, the study was conducted by Dr. Ramprasath Vanu Ramkumar, Adjunct Professor and Research Associate for the Department of Human Nutritional Sciences at the University of Manitoba.
"When initially developing the study outline for Youngevity, it was critical to investigate the important areas where the products could be of benefit and demonstrate a high level of safety, I believe we have accomplished that, these were very well thought out studies," said Dr. Peter Jones, RCFFN Director.
Youngevity Research Study Results:
Safety: RCFFN tested various levels of organ functions and metabolism to demonstrate the safety of Beyond Tangy Tangerine 2.0, Beyond OsteoFx 2.0, and Ultimate Essential Fatty Acids. The biochemical indicators and measurement showed normal functioning and metabolism of the liver, kidneys, and heart after supplementation with Beyond Tangy Tangerine 2.0 and the Healthy Start Pak 2.0 demonstrate no adverse reactions to these organs.
Weight Loss: Consumption of the Beyond Tangy Tangerine 2.0 as well as the Healthy Start Pak 2.0 significantly reduced the absolute weights of White Adipose Tissue (WAT) as well as WAT weight percentage of whole body weight. The study showed a significant reduction in adipose tissue weight and body fat mass.
Bone Health: Significant reductions in plasma concentrations of Alkaline Phosphatase, ALKP, an enzyme that promotes breakdown of bone were observed along with increases in concentrations of the bone building minerals, calcium and phosphorus.
Support for Normal Inflammatory Response: Inflammation was induced in the animal models by feeding them a high fat and sugar diet that triggers the Interleukin-6 inflammatory marker. After supplementation with both the Beyond Tangy Tangerine 2.0 and Healthy Start Pak 2.0 a significant reduction of the inflammatory marker was observed demonstrating support for normal inflammatory responses when placed under stressful conditions.
"It's very important that studies such as these are done in a unbiased, highly respected, academic setting. Consumers can feel confident in the results of these studies because of the "arms length" relationship that RCFFN had with Youngevity, we reported everything we found," said Dr. Ramprasath Vanu Ramkumar, University of Manitoba Associate Professor.
"Building on the previous research Youngevity performed with Clemson University, the RCFFN study results further substantiate the incredible potential value and benefit our consumers can receive with the Youngevity products. Youngevity is one of the few companies that provide such comprehensive research along with their products and we are proud to do so," said Sanjeev Javia, Youngevity Scientific Advisory Board Member.
“For over 15 years, Youngevity has been committed to science backed nutrition and providing the highest quality nutrients, dietary supplements, and wellness products to our distributors and customers,” said Steve Wallach, CEO and Chairman of Youngevity. “We are very excited and proud of the research results achieved on our signature products by the world-class researchers at the prestigious Richardson Center for Functional Foods and Nutraceuticals. The research studies performed on our products at Clemson University in 2012 and the University of Manitoba provide further support for the value and health benefits that we believe can be obtained from our products and Youngevity’s dedication to research and innovation."
About Youngevity International Inc.
Youngevity International Inc., (OTCQX: YGYI) (www.YGYI.com) is a fast-growing, innovative, multi-dimensional company that offers a wide range of consumer products and services, primarily through person-to-person selling relationships that comprise a "network of networks." The Company also is a vertically-integrated producer of the finest coffees for the commercial, retail and direct sales channels. The Company was formed after the merger of Youngevity Essential Life Sciences (www.youngevity.com) and Javalution Coffee Company in the summer of 2011. The company was formerly known as AL International, Inc. and changed its name to Youngevity International Inc. in July 2013.
Safe Harbor Statement
This release includes forward-looking statements on our current expectations and projections about future events, including our continued growth. In some cases forward-looking statements can be identified by terminology such as "may," "should," "potential," "continue," "expects," "anticipates," "intends," "plans," "believes," "estimates," “encouraged” and similar expressions. The forward looking statements include statements regarding our expected future growth, international expansion and improved profit. These statements are based upon current beliefs, expectations and assumptions and are subject to a number of risks and uncertainties, many of which are difficult to predict such as our ability to continue our financial performance. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release based on new information, future events, or otherwise, except as required by law.
Youngevity International, Inc. - Investor Relations
John Zervas
800-982-3189 X 6509
